OptiBiotix Health plc
OPTBF
$0.11
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 113.67% | 100.46% | 109.01% | 108.36% | -20.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 113.67% | 100.46% | 109.01% | 108.36% | -20.76% |
| Cost of Revenue | 63.02% | 52.96% | 194.23% | 193.49% | -13.82% |
| Gross Profit | 189.14% | 171.02% | 40.06% | 39.47% | -29.22% |
| SG&A Expenses | 61.95% | 51.91% | 31.22% | 30.81% | 30.83% |
| Depreciation & Amortization | 1.79% | -4.46% | -17.47% | -17.15% | 14.95% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.33% | 47.57% | 50.50% | 50.04% | 21.75% |
| Operating Income | -42.74% | -33.88% | -32.19% | -31.78% | -41.35% |
| Income Before Tax | 55.25% | 58.02% | 608.86% | 607.61% | -52.15% |
| Income Tax Expenses | 20.00% | 25.49% | -1,456.00% | -1,480.00% | 0.00% |
| Earnings from Continuing Operations | 55.35% | 58.11% | 626.61% | 624.96% | -52.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 55.35% | 58.11% | 626.61% | 624.96% | -52.38% |
| EBIT | -42.74% | -33.88% | -32.19% | -31.78% | -41.35% |
| EBITDA | -47.27% | -38.11% | -37.40% | -37.01% | -44.82% |
| EPS Basic | 58.60% | 61.50% | 576.92% | 584.62% | -41.98% |
| Normalized Basic EPS | -24.49% | -14.00% | -32.56% | -29.55% | -11.36% |
| EPS Diluted | 58.60% | 61.50% | 576.92% | 584.62% | -41.98% |
| Normalized Diluted EPS | -24.49% | -14.00% | -32.56% | -29.55% | -11.36% |
| Average Basic Shares Outstanding | 8.39% | 8.39% | 10.04% | 10.04% | 7.00% |
| Average Diluted Shares Outstanding | 8.39% | 8.39% | 10.04% | 10.04% | 7.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |